跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Tamzor - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Tamzor
Approved
STANDARD
Tamzor
Stallion Laboratories Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
10d88f06bbc40987
Company
Stallion Laboratories Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
10d88f06bbc40987
Drug Approval Philippines Name
Tamzor
Product Name
Tamzor
Registration Number
DRP-5272-03
Brand Name
Tamzor
Generic Name
Tamsulosin Hydrochloride
Dosage Form
Prolonged Release Capsule
Dosage Strength
200 mcg
Manufacturer
Stallion Laboratories Pvt. Ltd.
Importer
Ambica International Corporation
Distributor
The Cathay Drug Co., Inc.
Issuance Date
24 April 2024
Expiry Date
22 April 2029
Pharmacologic Category
Alpha-adrenoreceptor Antagonist
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
10d88f06bbc40987
Type
Standard
Back to Philippines FDA Approvals